ArticleDermatologic therapy2020
Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine.
Article in Dermatologic therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Severe and life-threatening COVID-19-related mucocutaneous eruptions: A systematic review.International journal of clinical practice · 2021Pooled it
- A systematic review of the histopathologic survey on skin biopsies in patients with Corona Virus Disease 2019 (COVID-19) who developed virus or drug-related mucocutaneous manifestations.Experimental dermatology · 2021Pooled it
- A systematic review on treatment-related mucocutaneous reactions in COVID-19 patients.Dermatologic therapy · 2021Pooled it
- Acute Generalized Exanthematous Pustulosis: Clinical Features, Differential Diagnosis, and Management.American journal of clinical dermatology · 2023Review
- Article
- A case of acute generalized exanthematous pustulosis following COVID-19 infection and remdesivir.Clinical case reports · 2023Article
- COVID-19 infection leading to acute pustular dermatoses.Archives of dermatological research · 2023Review
- Clinical features of acute generalized exanthematous pustulosis caused by hydroxychloroquine in rheumatology patients and exploration ofFrontiers in medicine · 2023Article
- Acute generalized exanthematous pustulosis: a complication of COVID-19 infection or therapy?Journal of cosmetic dermatology · 2022Article
- Cutaneous manifestations of COVID-19 among healthcare workers: A Case report and literature review.Clinical case reports · 2022Article
- Generalized exanthema due to hydroxychloroquine during COVID-19 prophylaxis.International journal of clinical practice · 2021Article
- Acute Generalized Exanthematous Pustulosis After COVID-19 Infection: A Case Report From Saudi Arabia.Cureus · 2020Article
- Delayed Presentation of Acute Generalized Exanthematous Pustulosis Following Treatment with Cefepime in a Patient with COVID-19 without the Use of Hydroxychloroquine.The American journal of case reports · 2020Article
- Cutaneous Manifestations in Adult Patients with COVID-19 and Dermatologic Conditions Related to the COVID-19 Pandemic in Health Care Workers.Current allergy and asthma reports · 2020Review
- [Cutaneous manifestations in COVID-19: current state].The Pan African medical journal · 2020Article
Corrections and comments
- Comment on
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.